{"id":"https://openalex.org/W2015659015","doi":"https://doi.org/10.1016/j.ijpharm.2007.11.008","title":"Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats","display_name":"Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats","publication_year":2007,"publication_date":"2007-12-05","ids":{"openalex":"https://openalex.org/W2015659015","doi":"https://doi.org/10.1016/j.ijpharm.2007.11.008","mag":"2015659015","pmid":"https://pubmed.ncbi.nlm.nih.gov/18082345"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2007.11.008","doi":"https://doi.org/10.1016/j.ijpharm.2007.11.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2007.11.008","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015659015"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://ousar.lib.okayama-u.ac.jp/34167","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111937584","display_name":"Jun-ichi Yokoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]},{"id":"https://openalex.org/I4210138195","display_name":"Nipro (Japan)","ror":"https://ror.org/03creg496","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210138195"]},{"id":"https://openalex.org/I4405264851","display_name":"Nipro Corporation (Japan)","ror":"https://ror.org/035649778","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"J YOKOE","raw_affiliation_strings":["Pharmaceutical Research Division, NIPRO Corporation, Shiga, Japan","Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan","Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]},{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan","institution_ids":["https://openalex.org/I163770644"]},{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S SAKURAGI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138195","display_name":"Nipro (Japan)","ror":"https://ror.org/03creg496","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210138195"]},{"id":"https://openalex.org/I4405264851","display_name":"Nipro Corporation (Japan)","ror":"https://ror.org/035649778","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S SAKURAGI","raw_affiliation_strings":["Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105274292","display_name":"K YAMAMOTO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138195","display_name":"Nipro (Japan)","ror":"https://ror.org/03creg496","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210138195"]},{"id":"https://openalex.org/I4405264851","display_name":"Nipro Corporation (Japan)","ror":"https://ror.org/035649778","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K YAMAMOTO","raw_affiliation_strings":["Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097311880","display_name":"T TERAGAKI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T TERAGAKI","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan","institution_ids":["https://openalex.org/I163770644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019436239","display_name":"Ken\u2010ichi Ogawara","orcid":"https://orcid.org/0000-0003-1307-7122","observed_orcids":["https://orcid.org/0000-0003-1307-7122"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K OGAWARA","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan","institution_ids":["https://openalex.org/I163770644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085916499","display_name":"Kazutaka Higaki","orcid":"https://orcid.org/0000-0002-0824-8575","observed_orcids":["https://orcid.org/0000-0002-0824-8575"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K HIGAKI","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan","institution_ids":["https://openalex.org/I163770644"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N KATAYAMA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138195","display_name":"Nipro (Japan)","ror":"https://ror.org/03creg496","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210138195"]},{"id":"https://openalex.org/I4405264851","display_name":"Nipro Corporation (Japan)","ror":"https://ror.org/035649778","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"N KATAYAMA","raw_affiliation_strings":["Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074454623","display_name":"Toshiya Kai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138195","display_name":"Nipro (Japan)","ror":"https://ror.org/03creg496","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210138195"]},{"id":"https://openalex.org/I4405264851","display_name":"Nipro Corporation (Japan)","ror":"https://ror.org/035649778","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T KAI","raw_affiliation_strings":["Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M SATO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138195","display_name":"Nipro (Japan)","ror":"https://ror.org/03creg496","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210138195"]},{"id":"https://openalex.org/I4405264851","display_name":"Nipro Corporation (Japan)","ror":"https://ror.org/035649778","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M SATO","raw_affiliation_strings":["Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, NIPRO Corporation, Shiga 525-0055, Japan","institution_ids":["https://openalex.org/I4210138195","https://openalex.org/I4405264851"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083294804","display_name":"Tomohiko Kimura","orcid":"https://orcid.org/0000-0003-3986-9494","observed_orcids":["https://orcid.org/0000-0003-3986-9494"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"T KIMURA","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan","institution_ids":["https://openalex.org/I163770644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5083294804"],"corresponding_institution_ids":["https://openalex.org/I163770644"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.7871,"has_fulltext":false,"cited_by_count":79,"citation_normalized_percentile":{"value":0.80617074,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"353","issue":"1-2","first_page":"28","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposomal-doxorubicin","display_name":"liposomal doxorubicin","score":0.9459999799728394},{"id":"https://openalex.org/keywords/peg-liposomes","display_name":"PEG-liposomes","score":0.7609999775886536},{"id":"https://openalex.org/keywords/recombinant-human-serum-albumin","display_name":"recombinant human serum albumin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/albumin-conjugation","display_name":"albumin conjugation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.6919999718666077},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9649999737739563},{"id":"https://openalex.org/keywords/tumor-accumulation","display_name":"tumor accumulation","score":0.6710000038146973},{"id":"https://openalex.org/keywords/hepatic-clearance","display_name":"hepatic clearance","score":0.652999997138977},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.8410000205039978},{"id":"https://openalex.org/keywords/heterobifunctional-crosslinker","display_name":"heterobifunctional crosslinker","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.938156008720398},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.7036978006362915},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6610438823699951},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6284931302070618},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5827173590660095},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5131757855415344},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.4655300974845886},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33463191986083984},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21137499809265137},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2036018967628479},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12936365604400635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10638532042503357},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012513","descriptor_name":"Sarcoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012513","descriptor_name":"Sarcoma, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ijpharm.2007.11.008","doi":"https://doi.org/10.1016/j.ijpharm.2007.11.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2007.11.008","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:18082345","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18082345","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:EPrintsOUDIR.lib.okayama-u.ac.jp:34167","doi":null,"is_oa":false,"landing_page_url":"https://ousar.lib.okayama-u.ac.jp/34167","pdf_url":null,"source":{"id":"https://openalex.org/S4377196325","display_name":"Okayama University Scientific Achievement Repository (Okayama University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I163770644","host_organization_name":"Okayama University","host_organization_lineage":["https://openalex.org/I163770644"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01081:0000649579","doi":null,"is_oa":true,"landing_page_url":"https://ousar.lib.okayama-u.ac.jp/34167","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal article"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01081:0000649579","doi":null,"is_oa":true,"landing_page_url":"https://ousar.lib.okayama-u.ac.jp/34167","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W20305632","https://openalex.org/W153049307","https://openalex.org/W1535876276","https://openalex.org/W1570509890","https://openalex.org/W1593844282","https://openalex.org/W1597997684","https://openalex.org/W1773975057","https://openalex.org/W1775749144","https://openalex.org/W1970239046","https://openalex.org/W1980775178","https://openalex.org/W1985561401","https://openalex.org/W1995195362","https://openalex.org/W2002516695","https://openalex.org/W2007106991","https://openalex.org/W2017794553","https://openalex.org/W2018925122","https://openalex.org/W2028065774","https://openalex.org/W2037563014","https://openalex.org/W2038647187","https://openalex.org/W2039884231","https://openalex.org/W2042249476","https://openalex.org/W2050670953","https://openalex.org/W2058120775","https://openalex.org/W2062847713","https://openalex.org/W2063623981","https://openalex.org/W2070005495","https://openalex.org/W2074544404","https://openalex.org/W2077120308","https://openalex.org/W2085508149","https://openalex.org/W2087526401","https://openalex.org/W2092652665","https://openalex.org/W2093353723","https://openalex.org/W2099374439","https://openalex.org/W2109141943","https://openalex.org/W2112468697","https://openalex.org/W2117358807","https://openalex.org/W2117808908","https://openalex.org/W2122440351","https://openalex.org/W2161580101","https://openalex.org/W2267226185","https://openalex.org/W3152092299"],"related_works":["https://openalex.org/W2050670953","https://openalex.org/W1570509890","https://openalex.org/W2150135298","https://openalex.org/W1975298683","https://openalex.org/W2343627246","https://openalex.org/W2133756116","https://openalex.org/W2057165359","https://openalex.org/W2943622434","https://openalex.org/W2042825500","https://openalex.org/W2313793406"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}